| Autor: |
Raghunandan S; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA. sraghu2@emory.edu.; Emory University, Atlanta, GA, USA. sraghu2@emory.edu., Qayed M; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Emory University, Atlanta, GA, USA., Watkins BK; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Emory University, Atlanta, GA, USA., Graiser M; Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Gorfinkel L; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Westbrook A; Emory University, Atlanta, GA, USA., Gillespie S; Emory University, Atlanta, GA, USA., Bratrude B; Boston Children's Hospital, Boston, MA, USA., Petrovic A; Seattle Children's Hospital, Seattle, WA, USA., Suessmuth Y; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Emory University, Atlanta, GA, USA., Horan J; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Kean LS; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Langston AA; Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA. |
Full text from SpringerLink